abstract |
The present invention relates to a compound of formula (I), or a prodrug, pharmaceutically acceptable salt, enantiomer or diastereomer thereof, for the treatment and/or prevention of liver cancer (for use therein): [Formula I] In the above formula, R 1 to R 3 are as described herein. |